Home   Business   Article

Subscribe Now

Meet six from the longlist for #21toWatch in 2021



More news, no ads

LEARN MORE


Ahead of nominations to the #21toWatch Awards closing on Friday (January 6), here are six of the entries that have made the longlist so far.

The initiative, from PR and communications company cofinitive, recognises people, companies and the ‘things’ they create across the Cambridge region and the East of England.

The longlist, updated every Wednesday, will be whittled down by a judging panel to a top 21, to be revealed at a bespoke online event on March 4.

The Cambridge Independent is proud to support #21toWatch again this year. You can nominate online at cofinitive.com/21toWatch and follow #21toWatch on social media.

People

Carol Cheung

Carol Cheung. Picture: CIC
Carol Cheung. Picture: CIC

Carol is a deeptech venture capital investor. Her current investment focus is on autonomous systems, AI and machine learning, cloud computing, and fintech. Carol is principal at Cambridge Innovation Capital and currently manages CIC’s investment in Cytora and GeoSpock. What makes Carol one to watch is how her work is supporting and shaping world-leading companies within the Cambridge ecosystem.

Cornelius Palm

Cornelius Palm, co-founder of HappyrHealth
Cornelius Palm, co-founder of HappyrHealth

Cornelius is the co-founder of HappyrHealth, featured recently in the Cambridge Independent. His philosophical approach as a start-up is inspirational and he has embraced the Cambridge ecosystem whilst leveraging his experience in healthcare and business. 2020 was a great year for Cornelius and his co-founder Nicole Filzmoser as their augmented reality avatar reached its 12-month anniversary and they both collected their post-graduate degrees.

Companies

Flusso

Flusso technology. Picture: Philip Mynott
Flusso technology. Picture: Philip Mynott

Flusso is a fabless semiconductor company, spun-out from University of Cambridge, developing flow sensing solutions for use in low-cost, high-volume applications. Flusso's new FLS110 flow sensor, the world’s smallest flow sensor, is small enough to fit into virtually any product and could lead to new generations of home healthcare products from smart inhalers to fitness monitoring equipment.

Iceni Diagnostics

Iceni Diagnostics develops carbohydrate-based point-of-care diagnostics and vaccines for infectious diseases, using its unique, proprietary HPGR (Host-Pathogen Glycan Recognition) technology.

In response to COVID-19, Iceni Diagnostics has been able to develop a lateral flow test that is designed to reveal if live, intact virus is present, rather than just viral genetic material. This is one execution of their tests that are designed to be mass produced and disposable and so provides a useful frontline tool for preventing disease spread.

‘Things’

eqWave

EqWave technology
EqWave technology

Equivital's new eqWave social distancing and contact tracing wearable sensor gives workers and organisations peace of mind to continue operating effectively whilst adhering to social distancing guidelines. Accurate distance measurements are made using Ultra Wide Band (UWB) radio and Bluetooth giving centimetre levels of precision. Unlike other systems that are based on Bluetooth alone, the eqWave gives 360-degree coverage. The measurement accuracy is not compromised by interference from wearers’ bodies or objects in the line of sight between people.

Orca Scan

In the past 12 months, Orca Scan has gone from strength to strength. Developing solutions that have been built on simplified barcode tracking for asset tracking, its latest thinking is paperless, app-less contact tracing. The tool can also be used for fault reporting, health and safety checks, event registration, visitor check-in (replacing forms and touchscreens) and more, making Orca Scan, based at St John’s Innovation Centre in Cambridge, a strong contender in the things category for 2021.

Read more

Nominations are now open for the cofinitive #21toWatch Awards 2021



This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More